CB vs SER · P/E 14, rev $59.40B vs rev $56.0K
Chubb Ltd (CB) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. SER currently screens at market cap $29.7M.
Not investment advice. Open the CB and SER stock pages for the full models.
Not investment advice.